SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-16-005359
Filing Date
2016-05-10
Accepted
2016-05-10 17:17:06
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_033116.htm 10-Q 473491
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11650
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 11699
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5093
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5057
  Complete submission text file 0001387131-16-005359.txt   2027699

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20160331.xml EX-101.INS 245910
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20160331.xsd EX-101.SCH 23938
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20160331_cal.xml EX-101.CAL 38812
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20160331_def.xml EX-101.DEF 62807
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20160331_lab.xml EX-101.LAB 209299
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20160331_pre.xml EX-101.PRE 146706
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 161636878
SIC: 2834 Pharmaceutical Preparations